Is Amesite Inc (AMST) Stock a Good Investment?
Learn more about Amesite Inc's (AMST) stock grades for Value, Momentum and Growth and determine whether this Software stock meets your investment needs.Jack Gilleland
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Amesite Inc., a technology company, engages in the marketing and development of B2C and B2B AI-driven solutions in the United States. Its products include Amesite Engage, that leverages proprietary AI infrastructure, offering cutting-edge applications that cater to both individual and professional needs; and NurseMagic, mobile healthcare app, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situation. Amesite Inc. was founded in 2017 and is headquartered in Detroit, Michigan.
Commentary & Analysis
Financial Summary
| Share Statistics | AMST | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $6.9 | $90.5 | 4% |
|
| Shares Out (Mil) | 4.6 | 17.5 | 13% |
|
| Institutional Ownership | 12.1% | 58.3% | 7% |
|
| Float (Mil) | 3.7 | 14.9 | 9% |
|
| Beta | 0.94 | 0.86 | 56% |
|
| Avg Daily Volume (000s) | 191 | 191 | 45% |
|
| Price Change (52-week) |
(60.8%) | 43.5% | 11% |
|
| Growth | AMST | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 0.0% | 5.6% | 17% |
|
| Net Income (5yr) | 3.0% | 13.3% | 44% |
|
| EPS (5yr) | 20.6% | 16.5% | 69 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (50.7%) | (15.2%) | 7% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | AMST | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $0 | $225 | 1% |
|
| Net Income (TTM) (Mil) | ($3) | $-0 | 35% |
|
| EPS (TTM) | ($0.650) | $0.000 | 25% |
|
| Operating Cash Flow (TTM) (Mil) | ($2) | $5 | 29% |
|
| Net Cash Flow (TTM) (Mil) | na | $1 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $18 | 0% |
|
| Enterprise Value (Q1) (Mil) | $6 | $151 | 6% |
|
| Valuation | AMST | Industry Median |
Percentile (All Stocks) |
|
| P/B | 3.89 | 1.90 | 72% |
|
| P/E | na | 17.0 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 0.5 | na |
|
| Ratios | AMST | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 100.0% | 47.2% | 96% |
|
| Net Margin | (871.9%) | 2.5% | 0% |
|
| ROA | (112.3%) | (0.8%) | 5% |
|
| ROE | (121.5%) | 5.2% | 8% |
|
| Liabilities to Assets | 12.7% | 49.7% | 8% |
|
| F-Score | 3 | 4 | 18% |
|
Amesite Inc. did not pass any screens on 9/2/2026.
